Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitrite Modulation of Hypertension, Platelet Activation, and Endothelial and Mitochondrial Function

NCT02517697 is registered in ClinicalTrials.gov with Gladwin, Mark, MD as lead sponsor.

NCT NCT02517697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02517697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitrite Modulation of Hypertension, Platelet Activation, and Endothelial and Mitochondrial Function
Lead sponsor
Gladwin, Mark, MD
Phase
Phase 2
Overall status
Withdrawn
Start date
October 31, 2020
Completion date
April 13, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, metabolic syndrome